Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Muriel Aguilar-Bretones

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
The Journal of Clinical Investigation|January 3, 2023
Impact of antigenic evolution and original antigenic sin on SARS-CoV-2 immunityMuriel Aguilar-Bretones, Ron Am Fouchier, Marion Pg Koopmans, et al.
Msphere|January 23, 2024
Human B cells and dendritic cells are susceptible and permissive to enterovirus D68 infectionBrigitta M Laksono, Syriam Sooksawasdi Na Ayudhya, Muriel Aguilar-Bretones, et al.
One Health (Amsterdam, Netherlands)|June 26, 2023
Novel approaches for the rapid development of rationally designed arbovirus vaccinesJoyce W M van Bree, Imke Visser, Jo M Duyvestyn, et al.
NPJ Vaccines|June 29, 2026
Proxy immunization enabling yellow fever vaccination after thymectomyEmilie C Rijnink, Muriel Aguilar-Bretones, Rory D de Vries, et al.
NPJ Vaccines|May 28, 2024
SARS-CoV-2-specific immune responses converge in kidney disease patients and controls with hybrid immunityMuriel Aguilar-Bretones, Yvette den Hartog, Laura L A van Dijk, et al.
Npj Viruses|March 20, 2026
SARS-CoV-2 crossreactive B-cells outnumber seasonal coronavirus spike-specific clones at the end of the COVID-19 pandemicCristina Gonzalez-Lopez, Muriel Aguilar-Bretones, Julian Reinders, et al.
The Journal of Clinical Investigation|September 9, 2021
Seasonal coronavirus-specific B cells with limited SARS-CoV-2 cross-reactivity dominate the IgG response in severe COVID-19Muriel Aguilar-Bretones, Brenda M Westerhuis, Matthijs P Raadsen, et al.
The Journal of Infection|January 10, 2026
Preferential boosting of SARS-CoV-2 Omicron lineage-specific immune responses by monovalent XBB.1.5 vaccinationDaryl Geers, Muriel Aguilar-Bretones, Luca M Zaeck, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
The Journal of Clinical Investigation|January 3, 2023
Impact of antigenic evolution and original antigenic sin on SARS-CoV-2 immunityMuriel Aguilar-Bretones, Ron Am Fouchier, Marion Pg Koopmans, et al.
Msphere|January 23, 2024
Human B cells and dendritic cells are susceptible and permissive to enterovirus D68 infectionBrigitta M Laksono, Syriam Sooksawasdi Na Ayudhya, Muriel Aguilar-Bretones, et al.
One Health (Amsterdam, Netherlands)|June 26, 2023
Novel approaches for the rapid development of rationally designed arbovirus vaccinesJoyce W M van Bree, Imke Visser, Jo M Duyvestyn, et al.
NPJ Vaccines|June 29, 2026
Proxy immunization enabling yellow fever vaccination after thymectomyEmilie C Rijnink, Muriel Aguilar-Bretones, Rory D de Vries, et al.
NPJ Vaccines|May 28, 2024
SARS-CoV-2-specific immune responses converge in kidney disease patients and controls with hybrid immunityMuriel Aguilar-Bretones, Yvette den Hartog, Laura L A van Dijk, et al.
Npj Viruses|March 20, 2026
SARS-CoV-2 crossreactive B-cells outnumber seasonal coronavirus spike-specific clones at the end of the COVID-19 pandemicCristina Gonzalez-Lopez, Muriel Aguilar-Bretones, Julian Reinders, et al.
The Journal of Clinical Investigation|September 9, 2021
Seasonal coronavirus-specific B cells with limited SARS-CoV-2 cross-reactivity dominate the IgG response in severe COVID-19Muriel Aguilar-Bretones, Brenda M Westerhuis, Matthijs P Raadsen, et al.
The Journal of Infection|January 10, 2026
Preferential boosting of SARS-CoV-2 Omicron lineage-specific immune responses by monovalent XBB.1.5 vaccinationDaryl Geers, Muriel Aguilar-Bretones, Luca M Zaeck, et al.
Pageof 1